On 18 July 2022, Haleon completed a demerger from GlaxoSmithKline to become the first independently listed company purely focused on consumer healthcare.
On 1 August 2019 we announced that we'd completed our transaction with Pfizer to combine our consumer healthcare businesses into a new world-leading Joint Venture.